IL6 and COVID-19: For COVID-19, dynamic changes in hematologic and immunologic markers, such as progressive decline in eosinophils, lymphocytes, and platelets and dynamic increases in NEUs, IL-6, PCT, D-dimer, and CRP, during hospitalization are indeed strong suggestions for progression of the disease.